Centrient Pharmaceuticals commits to reduce absolute scope 1 and 2 GHG emissions 46.20% by 2031 from 2022 base year*. Centrient Pharmaceuticals also commits to reduce absolute scope 3 GHG emissions from purchased goods and services and fuel and energy-related activities 27.50% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.